Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization
Tài liệu tham khảo
Ambati, 2003, Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies, Survey of Ophthalmology, 48, 257, 10.1016/S0039-6257(03)00030-4
An, 2006, Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors, Journal of Proteome Research, 5, 2599, 10.1021/pr060121j
Aprahamian, 2004, Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease, The Journal of Experimental Medicine, 199, 1121, 10.1084/jem.20031557
Asano, 2004, Masking of phosphatidylserine inhibits apoptotic cell engulfment and induces autoantibody production in mice, The Journal of Experimental Medicine, 200, 459, 10.1084/jem.20040342
Aslanian, 2006, Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis, Circulation, 114, 583, 10.1161/CIRCULATIONAHA.105.540583
Brown, 1980, Localization of cyclic nucleotide phosphodiesterase in the multicellular stages of Dictyostelium discoideum, Differentiation, 16, 173, 10.1111/j.1432-0436.1980.tb01073.x
Clemons, 2005, Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19, Ophthalmology, 112, 533, 10.1016/j.ophtha.2004.10.047
Cousins, 2004, Monocyte activation in patients with age-related macular degeneration: a biomarker of risk for choroidal neovascularization?, Archives of Ophthalmology, 122, 1013, 10.1001/archopht.122.7.1013
Crabb, 2002, Drusen proteome analysis: an approach to the etiology of age-related macular degeneration, Proceedings of the National Academy of Sciences of the United States of America, 99, 14682, 10.1073/pnas.222551899
Cuadrado, 2006, Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome, Journal of Thrombosis and Haemostasis, 4, 2461, 10.1111/j.1538-7836.2006.02193.x
Dineen, 2006, A proposed rapid methodology to assess the prevalence and causes of blindness and visual impairment, Ophthalmic Epidemiology, 13, 31, 10.1080/09286580500473787
Dunaief, 2002, The role of apoptosis in age-related macular degeneration, Archives of Ophthalmology, 120, 1435, 10.1001/archopht.120.11.1435
Forger, 2004, Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis, Lupus, 13, 36, 10.1191/0961203304lu485oa
Grossniklaus, 1992, Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration, American Journal of Ophthalmology, 114, 464, 10.1016/S0002-9394(14)71859-8
Gu, 2003, Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration, The Journal of Biological Chemistry, 278, 42027, 10.1074/jbc.M305460200
Haines, 2005, Complement factor H variant increases the risk of age-related macular degeneration, Science, 308, 419, 10.1126/science.1110359
Hoffmann, 2005, Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo, The Journal of Immunology, 174, 1393, 10.4049/jimmunol.174.3.1393
Joachim, 2006, Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with “wet” age-related macular degeneration, Graefe's Archive for Clinical and Experimental Ophthalmology, 245, 619, 10.1007/s00417-006-0429-9
Kamei, 2007, Scavenger receptors for oxidized lipoprotein in age-related macular degeneration, Investigative Ophthalmology & Visual Science, 48, 1801, 10.1167/iovs.06-0699
Kremmer, 2001, Antiphosphatidylserine antibodies are elevated in normal tension glaucoma, Clinical and Experimental Immunology, 125, 211, 10.1046/j.1365-2249.2001.01578.x
Lambooij, 2003, Insulin-like growth factor-I and its receptor in neovascular age-related macular degeneration, Investigative Ophthalmology & Visual Science, 44, 2192, 10.1167/iovs.02-0410
Li, 2007, Protein array autoantibody profiles for insights into systemic lupus erythematosus and incomplete lupus syndromes, Clinical and Experimental Immunology, 147, 60, 10.1111/j.1365-2249.2006.03251.x
Mantel, 2008, Macular and retinal dysfunction of unknown origin in adults with normal fundi: evidence for an autoimmune pathophysiology, Experimental and Molecular Pathology, 84, 90, 10.1016/j.yexmp.2007.10.006
Matsuda, 1994, Anti-annexin V antibody in systemic lupus erythematosus patients with lupus anticoagulant and/or anticardiolipin antibody, American Journal of Hematology, 47, 56, 10.1002/ajh.2830470112
Morohoshi, 2009, Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration, Journal of Autoimmunity, 33, 247, 10.1016/j.jaut.2009.09.003
Mullins, 2000, Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease, The FASEB Journal, 14, 835, 10.1096/fasebj.14.7.835
Muraro, 2002, T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients, Journal of Neuroimmunology, 130, 233, 10.1016/S0165-5728(02)00229-1
Norgren, 2004, Neurofilament and glial fibrillary acidic protein in multiple sclerosis, Neurology, 63, 1586, 10.1212/01.WNL.0000142988.49341.D1
Otsuka, 2005, Phosphatidylserine-specific receptor contributes to TGF-beta production in macrophages through a MAP kinase, ERK, Biological & Pharmaceutical Bulletin, 28, 1707, 10.1248/bpb.28.1707
Patel, 2005, Circulating anti-retinal antibodies as immune markers in age-related macular degeneration, Immunology, 115, 422, 10.1111/j.1365-2567.2005.02173.x
Penfold, 1990, Autoantibodies to retinal astrocytes associated with age-related macular degeneration, Graefe's Archive for Clinical and Experimental Ophthalmology, 228, 270, 10.1007/BF00920033
Pierangeli, 1999, Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo, Circulation, 99, 1997, 10.1161/01.CIR.99.15.1997
Rampazzo, 2001, Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins, Thrombosis and Haemostasis, 85, 57, 10.1055/s-0037-1612904
Rosenthal, 2004, Insulin-like growth factor-1 contributes to neovascularization in age-related macular degeneration, Biochemical and Biophysical Research Communications, 323, 1203, 10.1016/j.bbrc.2004.08.219
Sanna, 2000, Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations, Lupus, 9, 573, 10.1191/096120300678828695
Simantov, 1995, Activation of cultured vascular endothelial cells by antiphospholipid antibodies, The Journal of Clinical Investigation, 96, 2211, 10.1172/JCI118276
Sivaprasad, 2005, Serum elastin-derived peptides in age-related macular degeneration, Investigative Ophthalmology & Visual Science, 46, 3046, 10.1167/iovs.04-1277
Suvajac, 2007, Ocular manifestations in antiphospholipid syndrome, Autoimmunity Reviews, 6, 409, 10.1016/j.autrev.2006.11.005
Umeda, 2005, Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis), The FASEB Journal, 19, 1683, 10.1096/fj.04-3525fje
Vega-Ostertag, 2007, Role of p38 mitogen-activated protein kinase in antiphospholipid antibody-mediated thrombosis and endothelial cell activation, Journal of Thrombosis and Haemostasis, 5, 1828, 10.1111/j.1538-7836.2007.02680.x
Vogel, 1988, Molecular structure, localization, and possible functions of the myelin-associated enzyme 2′,3′-cyclic nucleotide 3′-phosphodiesterase, Journal of Neurochemistry, 50, 1667, 10.1111/j.1471-4159.1988.tb02461.x